| Product Code: ETC10772513 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Fiji continued to rely on key exporters like Australia, New Zealand, India, Bangladesh, and the USA for peripheral intervention drug-eluting devices. Despite a slight decline in growth rate from 2023 to 2024, the market maintained a high concentration with a Herfindahl-Hirschman Index (HHI) reflecting strong competitiveness. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 6.89%, indicating steady expansion in the market. Fiji`s import landscape for these devices showcases a consistent demand and strategic partnerships with leading exporting nations.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Peripheral Intervention Drug-Eluting Devices Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Peripheral Intervention Drug-Eluting Devices Market - Industry Life Cycle |
3.4 Fiji Peripheral Intervention Drug-Eluting Devices Market - Porter's Five Forces |
3.5 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.6 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Coating Material, 2021 & 2031F |
3.7 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Fiji Peripheral Intervention Drug-Eluting Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of peripheral artery disease in Fiji |
4.2.2 Growing adoption of minimally invasive procedures for peripheral interventions |
4.2.3 Technological advancements in drug-eluting devices for peripheral interventions |
4.3 Market Restraints |
4.3.1 High cost associated with drug-eluting devices |
4.3.2 Limited access to advanced healthcare facilities in remote areas of Fiji |
5 Fiji Peripheral Intervention Drug-Eluting Devices Market Trends |
6 Fiji Peripheral Intervention Drug-Eluting Devices Market, By Types |
6.1 Fiji Peripheral Intervention Drug-Eluting Devices Market, By Device Type |
6.1.1 Overview and Analysis |
6.1.2 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Device Type, 2021 - 2031F |
6.1.3 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Stents, 2021 - 2031F |
6.1.4 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Drug-Eluting Balloons, 2021 - 2031F |
6.1.5 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Stents, 2021 - 2031F |
6.1.6 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Based Stents, 2021 - 2031F |
6.1.7 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hybrid Coated Stents, 2021 - 2031F |
6.2 Fiji Peripheral Intervention Drug-Eluting Devices Market, By Coating Material |
6.2.1 Overview and Analysis |
6.2.2 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sirolimus, 2021 - 2031F |
6.2.3 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Paclitaxel, 2021 - 2031F |
6.2.4 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Everolimus, 2021 - 2031F |
6.2.5 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Zotarolimus, 2021 - 2031F |
6.2.6 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Rapamycin, 2021 - 2031F |
6.3 Fiji Peripheral Intervention Drug-Eluting Devices Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Peripheral Artery Disease, 2021 - 2031F |
6.3.3 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Chronic Limb Ischemia, 2021 - 2031F |
6.3.4 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.5 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Aneurysm Repair, 2021 - 2031F |
6.3.6 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Stenosis Treatment, 2021 - 2031F |
6.4 Fiji Peripheral Intervention Drug-Eluting Devices Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.4 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Ambulatory Centers, 2021 - 2031F |
6.4.5 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Cardiac Care Centers, 2021 - 2031F |
6.5 Fiji Peripheral Intervention Drug-Eluting Devices Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Nanocoating, 2021 - 2031F |
6.5.3 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Biodegradable Coating, 2021 - 2031F |
6.5.4 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Sustained Drug Release, 2021 - 2031F |
6.5.5 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Polymer-Encapsulated, 2021 - 2031F |
6.5.6 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, By Targeted Drug Delivery, 2021 - 2031F |
7 Fiji Peripheral Intervention Drug-Eluting Devices Market Import-Export Trade Statistics |
7.1 Fiji Peripheral Intervention Drug-Eluting Devices Market Export to Major Countries |
7.2 Fiji Peripheral Intervention Drug-Eluting Devices Market Imports from Major Countries |
8 Fiji Peripheral Intervention Drug-Eluting Devices Market Key Performance Indicators |
8.1 Average procedure time for peripheral interventions |
8.2 Number of skilled healthcare professionals trained in using drug-eluting devices |
8.3 Patient satisfaction rates with outcomes of drug-eluting device interventions |
9 Fiji Peripheral Intervention Drug-Eluting Devices Market - Opportunity Assessment |
9.1 Fiji Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.2 Fiji Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Coating Material, 2021 & 2031F |
9.3 Fiji Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Fiji Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Fiji Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Fiji Peripheral Intervention Drug-Eluting Devices Market - Competitive Landscape |
10.1 Fiji Peripheral Intervention Drug-Eluting Devices Market Revenue Share, By Companies, 2024 |
10.2 Fiji Peripheral Intervention Drug-Eluting Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here